Related Experiment Video
Updated: Apr 26, 2026

A β-glucuronidase GUS Based Cell Death Assay
Published on: May 6, 2011
The Gβ5 protein regulates sensitivity to TRAIL-induced cell death in colon carcinoma
D Fuchs1, M Metzig2, M Bickeböller1
1Molecular Tumor Pathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Abstract:
Aberrant signaling via G protein-coupled receptors (GPCRs) is implicated in numerous diseases including colon cancer. The heterotrimeric G proteins transduce signals from GPCRs to various effectors. So far, the G protein subunit Gβ5 has not been studied in the context of cancer. Here we demonstrate that Gβ5 protects colon carcinoma cells from apoptosis induced by the death ligand TRAIL via different routes. The Gβ5 protein (i) causes a decrease in the cell surface expression of the TRAIL-R2 death receptor, (ii) induces the expression of the anti-apoptotic protein XIAP and (iii) activates the NF-κB signaling pathway. The intrinsic resistance to TRAIL-triggered apoptosis of colon cancer cells is overcome by antagonization of Gβ5. Based on these results, targeting of G proteins emerges as a novel therapeutic approach in the experimental treatment of colon cancer.
Insights
G protein subunit Gβ5 protects colon cancer cells from TRAIL-induced apoptosis by reducing death receptor expression and activating survival pathways. Targeting Gβ5 may offer a new therapeutic strategy for colon cancer treatment.
Area of Science:
- Molecular Biology
- Oncology
- Cell Signaling
Background:
- Aberrant signaling through G protein-coupled receptors (GPCRs) is linked to various diseases, including colon cancer.
- Heterotrimeric G proteins are key signal transducers for GPCRs, but the role of the Gβ5 subunit in cancer remains unexplored.
Purpose of the Study:
- To investigate the role of the G protein subunit Gβ5 in colon carcinoma cell survival and resistance to apoptosis.
- To explore the potential of targeting Gβ5 as a therapeutic strategy for colon cancer.
Main Methods:
- Investigated the effect of Gβ5 on apoptosis induced by the death ligand TRAIL in colon carcinoma cells.
- Assessed cell surface expression of the TRAIL-R2 death receptor.
- Measured the expression of the anti-apoptotic protein XIAP.
- Analyzed the activation of the NF-κB signaling pathway.
Main Results:
- Gβ5 confers resistance to TRAIL-induced apoptosis in colon carcinoma cells through multiple mechanisms.
- Gβ5 reduces the cell surface expression of the TRAIL-R2 death receptor.
- Gβ5 induces XIAP expression and activates the NF-κB signaling pathway.
- Antagonizing Gβ5 overcomes intrinsic resistance to TRAIL-triggered apoptosis in colon cancer cells.
Conclusions:
- Gβ5 plays a protective role against apoptosis in colon cancer cells.
- Targeting G proteins, specifically Gβ5, represents a novel therapeutic avenue for colon cancer treatment.
More Related Videos
08:51Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
GPCR Desensitization
TGF - β Signaling Pathway
Activation and Inactivation of G Proteins
Intracellular Signaling Affects Focal Adhesions
Some...
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...